Pan Cancer T

Rotterdam, The Netherlands

Pan Cancer T is a biotechnology company that develops T‑cell receptor T‑cell therapies to treat solid tumors.

$5.8M raised

Dec 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Pan Cancer T raised?

Pan Cancer T has raised $5.8M in total funding. The most recent round was Seed. The last funding was announced in December 2025.

Who are Pan Cancer T's investors?

Pan Cancer T's investors include InnovationQuarter, Thuja Capital, Van Herk Ventures, Erasmus MC, Ministry of Economic Affairs (Innovation Credit).

Where is Pan Cancer T headquartered?

Pan Cancer T is headquartered in Rotterdam, The Netherlands.

What does Pan Cancer T do?

Pan Cancer T is a biotechnology company that develops T‑cell receptor T‑cell therapies to treat solid tumors.

What stage is Pan Cancer T at?

Pan Cancer T is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 8, 2025.

MLA

"Pan Cancer T — Funding & Investors." VCBacked, December 8, 2025, https://www.vcbacked.co/company/pan-cancer-t. Accessed July 2, 2026.

APA

VCBacked. (2025). Pan Cancer T — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/pan-cancer-t

Wikipedia (cite web)

{{cite web |title=Pan Cancer T — Funding & Investors |url=https://www.vcbacked.co/company/pan-cancer-t |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 8, 2025.